27 - 31 AUGUST 2018 Paris, France

Microfluidics for health:
from science to business


Microfluidics for health:
from science to business


If you are interested in how technology drives healthcare,
if you are curious to learn more about the potential offered by microfluidics,
if you are a startuper, serial entrepreneur, student, healthcare specialist, PhD, researcher, engineer…

Join us !

The Summer School “Microfluidics for health: from science to business“ will take place in Paris, in France,
from the 27th to 31th August 2018 thanks to a partnership with :
Initiative EASI Paris Région with the support of Sanofi,
ESPCI Paris,
Institut Pierre-Gilles de Gennes,
Mairie de Paris,
DIM Elicit -Ile de France,
Institut Curie,
Université PSL,
Medicen Paris Region,
and France Brevet.


Students, PhD students : 200 euros incl. taxes

Post-docs, other academics (engineers, researchers…), healthcare professionals,
startupers and not-for-profit institutions: 400 euros incl. taxes

Private groups and for profit institutions: 1000 euros incl. taxes

The call for applications is closed since the 19th July


Jérôme Bibette

Jérôme Bibette

Klavs F. Jensen

Klavs F. Jensen

Andrew Griffiths

Andrew Griffiths

Jacques Lewiner

Jacques Lewiner

Claire Poyart

Claire Poyart

David Weitz

David Weitz

Florent Malloggi

Florent Malloggi

Jean-louis Viovy

Jean-Louis Viovy

Jean-François Boussard

Jean-François Boussard

Sébastien Clerc

Sébastien Clerc

Didier Patry.png

Didier Patry


Startups will pitch their service or project.


Summer school “Microfluidics for health: from science to business” from the 27th of August to the 31st of August, in Paris Region
Monday, the 27th of August 2018
9:00-10:00 Amphitheater, IPGG Welcome
10:00-12:00 Amphitheater, IPGG Physics of Microfluidics
Patrick Tabeling, ESPCI
12:00-14:00 Lobby, IPGG Lunch&Networking
14:00-16:00 Amphitheater, IPGG Organs on chip
Jean-Louis Viovy, Institut Curie
16:00-17:00 Amphitheater, IPGG Manipulating Cells with Microfluidics
Klavs Jensen, MIT
17:00-18:00 Hall A and B, IPGG Posters session&Networking
Tuesday, the 28th of August 2018
9:00-10:00 Amphitheater, IPGG Chemical Synthesis in Microfluidics
Klavs Jensen, MIT
10:00-11:00 Amphitheater, IPGG Introduction to microfabrication
Florent Malloggi, CEA
11:00-12:00 Amphitheater, IPGG Metabolic Diversification
Jerôme Bibette, ESPCI
12:00-14:00 Lobby, IPGG Lunch&Networking
14:00-15:00 Amphitheater, IPGG Metabolic Diversification
Jerôme Bibette, ESPCI
15:00-16:00 Amphitheater, IPGG Startups session: Astraveus, Elvesys, Poetis.
16:00-17:00 Amphitheater, IPGG Droplets
Andrew Griffiths, ESCPI
17:00-18:00 Hall A and B, IPGG Posters session&Networking
Wednesday, the 29th of August 2018
9:00-10:00 Amphitheater, IPGG Droplets
Andrew Griffiths, ESCPI
10:00-11:00 Amphitheater, IPGG Startups session: Inoveria, Laclarée, MilliDrop.
11:00-12:00 Amphitheater, IPGG Microflluidics and innovation
Jacques Lewiner
12:00-14:00 Lobby, IPGG Lunch&Networking

Technological platform,

Pratical work on microfluidics
17:00-18:00 Hall A and B, IPGG Posters session&Networking
Thursday, the 30th of August 2018
9:00-10:00 Amphitheater, IPGG Capillary microfluidics
David Weitz, Harvard University
10:00-11:00 Amphitheater, IPGG Commercialization of microfluidic technologies: dreams or reality?
Sébastien CLERC, Yole Developpement
11:00-12:00 Amphitheater, IPGG Microfluidic landscape of patents
Didier Patry, France Brevets
12:00-14:00 Lobby, IPGG Lunch&Networking

Technological platform,
Cochin Hospital

Visit of a Parisian hospital laboratory which uses microfluidics
technologies for medical diagnosis
Claire Poyart, Cochin hospital
Friday, the 31th of August 2018
9:00-10:00 Amphitheater, IPGG Ultra high sensitive detection
David Weitz, Harvard University
10:00-10:30 Amphitheater, IPGG All good reasons to choose Paris Region,
Jean-François Boussard, Medicen Paris Region
10:30-11:00 Amphitheater, IPGG General discussion
11:00-12:00 Amphitheater, IPGG Closing session

Location and attendees info


Pierre-Gilles de Gennes Institute - IPGG
6 rue Jean Calvin
75005 Paris


How to get there?


EASI logo
Initiative EASI Paris Région with the support of Sanofi

Paris Region has an extremely rich health ecosystem. Many actors are involved to enrich its influence and release the energies at the service of the community. Initiative EASI Paris Région has been launched in 2016 with the support of Sanofi in order to facilitate the relationships between the healthcare ecosystem actors, boost attractiveness and enhance its national and international recognition l. EASI means the Excellence of the health ecosystem: Academic, Scientific and Industrial. Initiative EASI Paris Région brings together many actors. Co-chaired by Mr Bertrand Pulman, Professor of Sociology at Sorbonne Paris Cité and at the École des Hautes Études en Sciences sociales and Dr. Philippe Tcheng, Vice President of Governmental Relations France of Sanofi, a Committee of Wise Men gives guidelines to implement actions. In 2017, thanks to help of external experts, three working groups were set up on the following themes:
- promote the dissemination to young people of a scientific culture and a better knowledge of the health sector;
- set up cross-functional and multidisciplinary structure in Paris Region;
- health patient journey in oncology: optimization and prospective.


ESPCI Paris Tech is both an original Great Engineers School, a research Center internationally renowned and a fruitful generator of innovation for the Industry world. Founded in 1882 under the auspices of Paris City Hall, the school has attracted for more than a century the greatest innovative scientific minds: Pierre and Marie Curie, Paul Langevin, Frédéric Joliot-Curie, Pierre-Gilles de Gennes and Georges Charpak are such distinguished names who contribute to the ESPCI Paris Tech reputation, notably abroad.

IPGG logo
Institut Pierre-Gilles de Gennes

Talking of the Industry world and Research, Pierre-Gilles de Gennes used to say that « both have everything to gain by working together ». Regarding the frontiers between scientific domains, he stressed that we should be able to overcome them in order to make the domains more successful and fully exploit their potentials. Pierre-Gilles de Gennes Institute – IPGG – has been created along these lines of thought: its goal is to bring together, in a cross-disciplinary domain (microfluidics), experts from various disciplines (physics, biology, chemistry, technology), and develop both fundamental and applied research. Industrial domains interested by microfluidics are numerous (food industry, medicinal field, cosmetics, oil industry, instrumentation...).

Mairie de Paris logo
Mairie de Paris

Dim-Elicit-Ile de France logo
DIM – Elicit - Ile de France

DIM ELICIT “Empowering LIfe sCiences with Innovative Technologies” co-leaded by the Institut Pierre Gilles de Gennes for microfluidics (IPGG, Patrick Tabeling) and the Institut Pasteur (Jean-Christophe Olivo-Marin and Elodie Brient-Litzler) has been labelled by the Conseil Regional d’Ile-de-France on the 15th of December, 2016 to support research on three core technologies: Microfluidics / Biophotonics and Waves / Image analysis and Big data. The DIM ELICIT aim at supporting interdisciplinary collaborative research projects of:

      • first applications of new technologies or innovative instruments for Biology;
      • implementation of disruptive technologies in Biology, the disruptive criteria being assessed regarding the impact and the transformative nature;
      • integration in the SME and industrial value-added chain, in particular in Ile-de-France, in the area of Technologies for Life Sciences (including start-ups creation).
In order to be one of the most innovative ecosystem in the field of Technologies for Life Sciences, the DIM ELICIT wishes to bring together stakeholders from all Ile-de-France in one and only network. -
ENS logo

L’École normale supérieure (ENS) is a high education etablishment for undergraduate and graduate studies (graduate school), and a prestigious place for research. It welcomes fourteen teaching and research departments, covering most of the literary and scientific fields.

Institut Curie logo
Institut Curie

A leading player in the fight against cancer, Institut Curie brings together an internationally-renowned research centre and an advanced hospital group that provides care for all types of cancer – including the rarest forms.
Founded in 1909 by Nobel laureate Marie Curie, Institut Curie comprises three sites (Paris, Saint-Cloud and Orsay), where more than 3,400 members of staff are dedicated to achieving three objectives: hospital care; scientific research; and the sharing of knowledge and the preserving of legacy.
As a private charitable foundation since 1921 that is recognised as serving the public interest, Institut Curie is supported by donations and grants. This support is used to fund discoveries that will improve treatment and the quality of life of cancer patients.

PSL logo
Université PSL

Université PSL (Paris Sciences & Lettres) offers an ideal environment for the development of academic excellence, creation and innovation: 4 500 researchers, 181 laboratories, 17 000 students and a dozen of incubators, fab-labs and co-working spaces for students and entrepreneurs in the heart of Paris.
Arts, sciences and engineering are at the core of its intellectual and scientific ambition. As a global selective university, rooted in interdisciplinarity and committed to promoting talents and defending equal opportunity, PSL creates the world of tomorrow.

Université PSL : Chimie ParisTech, École nationale des chartes, École normale supérieure, École Pratique des Hautes Études, ESPCI Paris, Institut Curie, MINES ParisTech, Observatoire de Paris, Université Paris-Dauphine.

Associates: Collège de France, Conservatoire national supérieur d’Art dramatique, Conservatoire national supérieur de Musique et de Danse de Paris, École des hautes études en sciences sociales, École française d'Extrême-Orient, École nationale supérieure des Arts Décoratifs, Beaux-Arts de Paris, IBPC-Fondation Edmond de Rothschild, Institut Louis Bachelier, La Fémis. With the support of: CNRS, Inserm, Inria.

BPI logo

Bpifrance is a public investment bank, a French organization for financing and business development. Bpifrance accompanies and develops the financing of companies: creation, acquisition or external growth, development through innovation, conquest of new markets in France or abroad. Bpifrance is presents throughout the country via its 37 regional offices.

Medicen logo
Medicen Paris Region

Medicen Paris Region is a competitiveness cluster for innovative health technologies, with national and international scope. With more than 400 companies, research centers, universities, hospitals and local authorities as members, it aims to position the Paris region as Europe’s leading healthcare cluster. It focuses on five strategic areas: biological diagnostics, diagnostic and interventional imaging, regenerative medicine and biomaterials, digital health and translational medicine. In close collaboration with local, regional and national healthcare innovation players, Medicen Paris Region aims to:

      • Foster the emergence, development and funding of certified collaborative projects in the healthcare sector, in order to create economic value and jobs
      • Increase the international development of innovative startups and SMEs
      • Strengthen the attractiveness of the Paris region, which represents more than 50% of olfe sciences activity in France
Since the creation of the cluster in 2005, 68 innovative products have been launched in the imaging, medical devices and biological tools sectors. The cluster has certified 302 projects. They received funding from the French government (French Inter-Ministry Fund FUI, Structuring Projects fund), the public investment bank Bpifrance, the National Research Agency, the European Regional Development Fund, the Investments for the Future program and/or local authorities, and the Paris region. Total investment is close to €1.9 billion ($2.3bn) and €533 million ($635M) of public aid.

France Brevet logo
Yole Développement logo

Contact us

E-mail: Initiative.easi.paris.region@sanofi.com